Escherichia fergusonii is a species of bacteria that is part of the Enterobacteriaceae family. Although E. fergusonii is commonly found in the gastrointestinal tracts of humans and animals, it has been increasingly recognized as an emerging opportunistic pathogen in recent years.
E. fergusonii has been isolated from various sources, including food, water, animals, and human clinical specimens such as blood, urine, stool, and wound cultures. E. fergusonii infections are relatively rare, and there is limited information on the epidemiology of E. fergusonii infections.
E. fergusonii is often misidentified as E. coli in clinical laboratories because of their similar characteristics. However, recent advances in molecular techniques have made distinguishing between these two species easier.
E. fergusonii has been implicated in many infections, including urinary tract infections, septicemia, meningitis, and wound infections. Risk factors for E. fergusonii infections include immunosuppression, underlying medical conditions, and contaminated food or water exposure.
Prevention and control of E. fergusonii infections are similar to those for other Enterobacteriaceae, including proper food handling and preparation, hand hygiene, and appropriate use of antibiotics. Furthermore, healthcare professionals must know the risk of E. fergusonii infections.
And consider it in the differential diagnosis of patients with clinical symptoms suggestive of Enterobacteriaceae infections.
Structurally, E. fergusonii is a rod-shaped bacterium with a length of approximately 2 to 3 micrometers and a width of approximately 0.5 to 1 micrometer. It has a single circular chromosome and can also carry plasmids. It is a facultative anaerobe that can survive in aerobic and anaerobic environments.
Classification of E. fergusonii is based on its genetic and phenotypic characteristics. It was first described in 1982, and its Classification has undergone revisions since then. E. fergusonii is classified as a separate species within the Escherichia genus based on its distinct genetic profile, including differences in its 16S ribosomal RNA gene sequence and the ability to metabolize specific substrates such as raffinose and maltose.
The Classification of Escherichia fergusonii is as follows:
Domain: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species: Escherichia fergusonii
E. fergusonii is also further classified into different biotypes based on its ability to ferment different sugars and its sensitivity to certain antibiotics. There are currently 11 known biotypes of E. fergusonii, which can be identified using various biochemical tests.
It is closely related to Escherichia coli and shares many antigenic characteristics. However, E. fergusonii has several unique antigens that differentiate it from E. coli.
The antigenic types of E. fergusonii are based on the presence of specific surface antigens called O-antigens. These polysaccharides are attached to the bacterium’s outer membrane and play a role in its virulence and recognition by the host immune system.
At least 10 O-antigen types have been identified in E. fergusonii, designated O1 to O10. These antigens are characterized by their unique chemical structures and can be detected using serological methods such as the slide agglutination test or enzyme-linked immunosorbent assay (ELISA).
E. fergusonii is considered a commensal organism, meaning it typically lives harmlessly in the human gut; it has also been associated with various infections in humans, particularly in immunocompromised individuals.
The pathogenesis of E. fergusonii is not fully understood, but it is believed to be similar to that of E. coli. Like E. coli, E. fergusonii can produce various virulence factors that contribute to its ability to cause disease. Some virulence factors include fimbriae, which allow the bacteria to adhere to host cells, and toxins, which can damage host tissues.
E. fergusonii has been associated with several infections, including urinary tract infections, bacteremia, and sepsis. In many cases, these infections are believed to occur when the bacteria can breach the host’s natural defenses and invade the bloodstream or other tissues.
The host defenses against E. fergusonii are similar to those against other Gram-negative bacteria, involving innate and adaptive immune responses.
Here are some examples:
Innate immune response: is the first defense against invading pathogens, including E. fergusonii. It includes physical barriers, such as the skin and mucous membranes, and various cells and molecules that can recognize and eliminate pathogens. Examples of innate immune defenses against E. fergusonii include:
Phagocytosis: Macrophages and neutrophils can recognize and engulf E. fergusonii, destroying it with enzymes and reactive oxygen species.
Complement system: This group of proteins can recognize and bind to E. fergusonii, marking it for destruction by phagocytes or lytic pore formation.
Cytokines and chemokines: These signaling molecules can activate immune cells and recruit them to the site of infection.
Adaptive immune response: The adaptive immune system develops more slowly and precisely in response to a pathogen. It includes B cells that produce antibodies and T cells that recognize and kill infected cells. The adaptive immune system can provide long-lasting immunity against E. fergusonii. Examples of adaptive immune defenses against E. fergusonii include:
Antibodies: B cells can produce antibodies that bind to E. fergusonii, neutralize its virulence factors, or mark it for destruction by phagocytes or complement proteins.
T cells: Certain T cells, such as cytotoxic T cells, can recognize and kill E. fergusonii infected cells.
Clinical manifestations of E. fergusonii infection can vary depending on the type and severity of the infection. The symptoms are usually mild and self-limiting, and the infection resolves independently without treatment. However, in severe cases, it can cause serious infections such as urinary tract infections, sepsis, and pneumonia.
Some of the common symptoms associated with E. fergusonii infection include:
Fever
Abdominal pain
Nausea and vomiting
Diarrhea
Urinary tract infections (UTIs)
Pneumonia
Sepsis
Diagnosing E. fergusonii involves identifying the organism through laboratory culture and biochemical testing. Some key characteristics of E. fergusonii that can aid in its identification include:
Growth on MacConkey agar: E. fergusonii can grow on MacConkey agar, a selective and differential medium commonly used to isolate Gram-negative bacteria.
Biochemical tests:E. fergusonii is typically negative for lactose fermentation and positive for urease production. It may also be positive for indole production and motility.
Molecular identification: DNA sequencing can be used to identify the presence of E. fergusonii based on specific genetic markers.
Here are some ways to control the growth and spread of Escherichia fergusonii:
Practice good hygiene: Good hygiene practices can help prevent the spread of Escherichia fergusonii. It is also essential to properly clean and sanitize surfaces and objects that may come into contact with the bacteria.
Antibiotic therapy: In case of infection, antibiotics can treat Escherichia fergusonii. However, it is crucial to use antibiotics only as directed by a healthcare professional, and to complete the entire course of treatment, even if symptoms improve.
Probiotics: Probiotics are beneficial bacteria that can help restore the balance of gut flora and prevent the growth of harmful bacteria, including Escherichia fergusonii. Probiotic-rich foods such as yogurt or probiotic supplements can help maintain a healthy gut.
Avoid contaminated food and water:Escherichia fergusonii can be present in contaminated food and water. To avoid infection, practicing food safety and drinking clean water is essential.
Environmental measures:Escherichia fergusonii can survive in soil and water, so environmental measures such as water treatment and soil disinfection can help control its growth and spread.
Escherichia fergusonii is a species of bacteria that is part of the Enterobacteriaceae family. Although E. fergusonii is commonly found in the gastrointestinal tracts of humans and animals, it has been increasingly recognized as an emerging opportunistic pathogen in recent years.
E. fergusonii has been isolated from various sources, including food, water, animals, and human clinical specimens such as blood, urine, stool, and wound cultures. E. fergusonii infections are relatively rare, and there is limited information on the epidemiology of E. fergusonii infections.
E. fergusonii is often misidentified as E. coli in clinical laboratories because of their similar characteristics. However, recent advances in molecular techniques have made distinguishing between these two species easier.
E. fergusonii has been implicated in many infections, including urinary tract infections, septicemia, meningitis, and wound infections. Risk factors for E. fergusonii infections include immunosuppression, underlying medical conditions, and contaminated food or water exposure.
Prevention and control of E. fergusonii infections are similar to those for other Enterobacteriaceae, including proper food handling and preparation, hand hygiene, and appropriate use of antibiotics. Furthermore, healthcare professionals must know the risk of E. fergusonii infections.
And consider it in the differential diagnosis of patients with clinical symptoms suggestive of Enterobacteriaceae infections.
Structurally, E. fergusonii is a rod-shaped bacterium with a length of approximately 2 to 3 micrometers and a width of approximately 0.5 to 1 micrometer. It has a single circular chromosome and can also carry plasmids. It is a facultative anaerobe that can survive in aerobic and anaerobic environments.
Classification of E. fergusonii is based on its genetic and phenotypic characteristics. It was first described in 1982, and its Classification has undergone revisions since then. E. fergusonii is classified as a separate species within the Escherichia genus based on its distinct genetic profile, including differences in its 16S ribosomal RNA gene sequence and the ability to metabolize specific substrates such as raffinose and maltose.
The Classification of Escherichia fergusonii is as follows:
Domain: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species: Escherichia fergusonii
E. fergusonii is also further classified into different biotypes based on its ability to ferment different sugars and its sensitivity to certain antibiotics. There are currently 11 known biotypes of E. fergusonii, which can be identified using various biochemical tests.
It is closely related to Escherichia coli and shares many antigenic characteristics. However, E. fergusonii has several unique antigens that differentiate it from E. coli.
The antigenic types of E. fergusonii are based on the presence of specific surface antigens called O-antigens. These polysaccharides are attached to the bacterium’s outer membrane and play a role in its virulence and recognition by the host immune system.
At least 10 O-antigen types have been identified in E. fergusonii, designated O1 to O10. These antigens are characterized by their unique chemical structures and can be detected using serological methods such as the slide agglutination test or enzyme-linked immunosorbent assay (ELISA).
E. fergusonii is considered a commensal organism, meaning it typically lives harmlessly in the human gut; it has also been associated with various infections in humans, particularly in immunocompromised individuals.
The pathogenesis of E. fergusonii is not fully understood, but it is believed to be similar to that of E. coli. Like E. coli, E. fergusonii can produce various virulence factors that contribute to its ability to cause disease. Some virulence factors include fimbriae, which allow the bacteria to adhere to host cells, and toxins, which can damage host tissues.
E. fergusonii has been associated with several infections, including urinary tract infections, bacteremia, and sepsis. In many cases, these infections are believed to occur when the bacteria can breach the host’s natural defenses and invade the bloodstream or other tissues.
The host defenses against E. fergusonii are similar to those against other Gram-negative bacteria, involving innate and adaptive immune responses.
Here are some examples:
Innate immune response: is the first defense against invading pathogens, including E. fergusonii. It includes physical barriers, such as the skin and mucous membranes, and various cells and molecules that can recognize and eliminate pathogens. Examples of innate immune defenses against E. fergusonii include:
Phagocytosis: Macrophages and neutrophils can recognize and engulf E. fergusonii, destroying it with enzymes and reactive oxygen species.
Complement system: This group of proteins can recognize and bind to E. fergusonii, marking it for destruction by phagocytes or lytic pore formation.
Cytokines and chemokines: These signaling molecules can activate immune cells and recruit them to the site of infection.
Adaptive immune response: The adaptive immune system develops more slowly and precisely in response to a pathogen. It includes B cells that produce antibodies and T cells that recognize and kill infected cells. The adaptive immune system can provide long-lasting immunity against E. fergusonii. Examples of adaptive immune defenses against E. fergusonii include:
Antibodies: B cells can produce antibodies that bind to E. fergusonii, neutralize its virulence factors, or mark it for destruction by phagocytes or complement proteins.
T cells: Certain T cells, such as cytotoxic T cells, can recognize and kill E. fergusonii infected cells.
Clinical manifestations of E. fergusonii infection can vary depending on the type and severity of the infection. The symptoms are usually mild and self-limiting, and the infection resolves independently without treatment. However, in severe cases, it can cause serious infections such as urinary tract infections, sepsis, and pneumonia.
Some of the common symptoms associated with E. fergusonii infection include:
Fever
Abdominal pain
Nausea and vomiting
Diarrhea
Urinary tract infections (UTIs)
Pneumonia
Sepsis
Diagnosing E. fergusonii involves identifying the organism through laboratory culture and biochemical testing. Some key characteristics of E. fergusonii that can aid in its identification include:
Growth on MacConkey agar: E. fergusonii can grow on MacConkey agar, a selective and differential medium commonly used to isolate Gram-negative bacteria.
Biochemical tests:E. fergusonii is typically negative for lactose fermentation and positive for urease production. It may also be positive for indole production and motility.
Molecular identification: DNA sequencing can be used to identify the presence of E. fergusonii based on specific genetic markers.
Here are some ways to control the growth and spread of Escherichia fergusonii:
Practice good hygiene: Good hygiene practices can help prevent the spread of Escherichia fergusonii. It is also essential to properly clean and sanitize surfaces and objects that may come into contact with the bacteria.
Antibiotic therapy: In case of infection, antibiotics can treat Escherichia fergusonii. However, it is crucial to use antibiotics only as directed by a healthcare professional, and to complete the entire course of treatment, even if symptoms improve.
Probiotics: Probiotics are beneficial bacteria that can help restore the balance of gut flora and prevent the growth of harmful bacteria, including Escherichia fergusonii. Probiotic-rich foods such as yogurt or probiotic supplements can help maintain a healthy gut.
Avoid contaminated food and water:Escherichia fergusonii can be present in contaminated food and water. To avoid infection, practicing food safety and drinking clean water is essential.
Environmental measures:Escherichia fergusonii can survive in soil and water, so environmental measures such as water treatment and soil disinfection can help control its growth and spread.
Escherichia fergusonii is a species of bacteria that is part of the Enterobacteriaceae family. Although E. fergusonii is commonly found in the gastrointestinal tracts of humans and animals, it has been increasingly recognized as an emerging opportunistic pathogen in recent years.
E. fergusonii has been isolated from various sources, including food, water, animals, and human clinical specimens such as blood, urine, stool, and wound cultures. E. fergusonii infections are relatively rare, and there is limited information on the epidemiology of E. fergusonii infections.
E. fergusonii is often misidentified as E. coli in clinical laboratories because of their similar characteristics. However, recent advances in molecular techniques have made distinguishing between these two species easier.
E. fergusonii has been implicated in many infections, including urinary tract infections, septicemia, meningitis, and wound infections. Risk factors for E. fergusonii infections include immunosuppression, underlying medical conditions, and contaminated food or water exposure.
Prevention and control of E. fergusonii infections are similar to those for other Enterobacteriaceae, including proper food handling and preparation, hand hygiene, and appropriate use of antibiotics. Furthermore, healthcare professionals must know the risk of E. fergusonii infections.
And consider it in the differential diagnosis of patients with clinical symptoms suggestive of Enterobacteriaceae infections.
Structure and Classification
Structurally, E. fergusonii is a rod-shaped bacterium with a length of approximately 2 to 3 micrometers and a width of approximately 0.5 to 1 micrometer. It has a single circular chromosome and can also carry plasmids. It is a facultative anaerobe that can survive in aerobic and anaerobic environments.
Classification of E. fergusonii is based on its genetic and phenotypic characteristics. It was first described in 1982, and its Classification has undergone revisions since then. E. fergusonii is classified as a separate species within the Escherichia genus based on its distinct genetic profile, including differences in its 16S ribosomal RNA gene sequence and the ability to metabolize specific substrates such as raffinose and maltose.
The Classification of Escherichia fergusonii is as follows:
Domain: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species: Escherichia fergusonii
E. fergusonii is also further classified into different biotypes based on its ability to ferment different sugars and its sensitivity to certain antibiotics. There are currently 11 known biotypes of E. fergusonii, which can be identified using various biochemical tests.
Antigenic Types
It is closely related to Escherichia coli and shares many antigenic characteristics. However, E. fergusonii has several unique antigens that differentiate it from E. coli.
The antigenic types of E. fergusonii are based on the presence of specific surface antigens called O-antigens. These polysaccharides are attached to the bacterium’s outer membrane and play a role in its virulence and recognition by the host immune system.
At least 10 O-antigen types have been identified in E. fergusonii, designated O1 to O10. These antigens are characterized by their unique chemical structures and can be detected using serological methods such as the slide agglutination test or enzyme-linked immunosorbent assay (ELISA).
Pathogenesis
E. fergusonii is considered a commensal organism, meaning it typically lives harmlessly in the human gut; it has also been associated with various infections in humans, particularly in immunocompromised individuals.
The pathogenesis of E. fergusonii is not fully understood, but it is believed to be similar to that of E. coli. Like E. coli, E. fergusonii can produce various virulence factors that contribute to its ability to cause disease. Some virulence factors include fimbriae, which allow the bacteria to adhere to host cells, and toxins, which can damage host tissues.
E. fergusonii has been associated with several infections, including urinary tract infections, bacteremia, and sepsis. In many cases, these infections are believed to occur when the bacteria can breach the host’s natural defenses and invade the bloodstream or other tissues.
Host Defences
The host defenses against E. fergusonii are similar to those against other Gram-negative bacteria, involving innate and adaptive immune responses.
Here are some examples:
Innate immune response: is the first defense against invading pathogens, including E. fergusonii. It includes physical barriers, such as the skin and mucous membranes, and various cells and molecules that can recognize and eliminate pathogens. Examples of innate immune defenses against E. fergusonii include:
Phagocytosis: Macrophages and neutrophils can recognize and engulf E. fergusonii, destroying it with enzymes and reactive oxygen species.
Complement system: This group of proteins can recognize and bind to E. fergusonii, marking it for destruction by phagocytes or lytic pore formation.
Cytokines and chemokines: These signaling molecules can activate immune cells and recruit them to the site of infection.
Adaptive immune response: The adaptive immune system develops more slowly and precisely in response to a pathogen. It includes B cells that produce antibodies and T cells that recognize and kill infected cells. The adaptive immune system can provide long-lasting immunity against E. fergusonii. Examples of adaptive immune defenses against E. fergusonii include:
Antibodies: B cells can produce antibodies that bind to E. fergusonii, neutralize its virulence factors, or mark it for destruction by phagocytes or complement proteins.
T cells: Certain T cells, such as cytotoxic T cells, can recognize and kill E. fergusonii infected cells.
Clinical manifestations
Clinical manifestations of E. fergusonii infection can vary depending on the type and severity of the infection. The symptoms are usually mild and self-limiting, and the infection resolves independently without treatment. However, in severe cases, it can cause serious infections such as urinary tract infections, sepsis, and pneumonia.
Some of the common symptoms associated with E. fergusonii infection include:
Fever
Abdominal pain
Nausea and vomiting
Diarrhea
Urinary tract infections (UTIs)
Pneumonia
Sepsis
Diagnosis
Diagnosing E. fergusonii involves identifying the organism through laboratory culture and biochemical testing. Some key characteristics of E. fergusonii that can aid in its identification include:
Growth on MacConkey agar: E. fergusonii can grow on MacConkey agar, a selective and differential medium commonly used to isolate Gram-negative bacteria.
Biochemical tests:E. fergusonii is typically negative for lactose fermentation and positive for urease production. It may also be positive for indole production and motility.
Molecular identification: DNA sequencing can be used to identify the presence of E. fergusonii based on specific genetic markers.
Control
Here are some ways to control the growth and spread of Escherichia fergusonii:
Practice good hygiene: Good hygiene practices can help prevent the spread of Escherichia fergusonii. It is also essential to properly clean and sanitize surfaces and objects that may come into contact with the bacteria.
Antibiotic therapy: In case of infection, antibiotics can treat Escherichia fergusonii. However, it is crucial to use antibiotics only as directed by a healthcare professional, and to complete the entire course of treatment, even if symptoms improve.
Probiotics: Probiotics are beneficial bacteria that can help restore the balance of gut flora and prevent the growth of harmful bacteria, including Escherichia fergusonii. Probiotic-rich foods such as yogurt or probiotic supplements can help maintain a healthy gut.
Avoid contaminated food and water:Escherichia fergusonii can be present in contaminated food and water. To avoid infection, practicing food safety and drinking clean water is essential.
Environmental measures:Escherichia fergusonii can survive in soil and water, so environmental measures such as water treatment and soil disinfection can help control its growth and spread.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
